Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Financial RestatementItem 4.02 · 8-KMEDIUM RiskNegative

SANUWAVE Health, Inc.

sanuwave.com
Filed: Mar 13, 2026SUWANEE, GACIK: 0001417663Biotechnology
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

SANUWAVE Health identified a historical state sales and use tax liability through a nexus study, requiring the company to restate prior financial statements and establish ongoing tax collection and remittance obligations. This discovery signals potential accounting control weaknesses and creates future compliance costs that could impact financial performance.

Key Takeaways

A third-party sales and use tax nexus study revealed previously unidentified historical tax liabilities across multiple state jurisdictions

The company must restate previously issued financial statements due to the identified tax obligations, indicating a material accounting adjustment

2 more takeaways

Filing Overview

Form Type8-K
Filing DateMar 13, 2026
Item4.02
CategoryFinancial Restatement
CIK0001417663
Accession #0001417663
Risk LevelMEDIUM
SentimentNegative
Signalrisk
Topics
regulatoryimpairment

What This Means

Previously issued financial statements should not be relied upon. This is a serious red flag indicating accounting errors.
View Full Filing on SEC.govBrowse More Filings